Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 107

    1.

    Graves disease induced by radioactive iodine.

    Kay TW, Heyma P, Harrison LC, Martin FI.

    Ann Intern Med. 1987 Dec;107(6):857-8. No abstract available. PMID: 3688680 [PubMed - indexed for MEDLINE]Related articles

    2.

    Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter.

    Nygaard B, Knudsen JH, Hegedüs L, Scient AV, Hansen JE.

    J Clin Endocrinol Metab. 1997 Sep;82(9):2926-30.PMID: 9284721 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre.

    Chiovato L, Santini F, Vitti P, Bendinelli G, Pinchera A.

    Clin Endocrinol (Oxf). 1994 Jun;40(6):803-6.PMID: 8033373 [PubMed - indexed for MEDLINE]Related articles

    4.

    Appearance of Graves'-like disease after radioiodine therapy for toxic as well as non-toxic multinodular goitre.

    Nygaard B, Faber J, Veje A, Hegedüs L, Hansen JM.

    Clin Endocrinol (Oxf). 1995 Jul;43(1):129-30. No abstract available. PMID: 7641405 [PubMed - indexed for MEDLINE]Related articles

    5.

    Subacute thyroiditis with highly positive thyrotropin receptor antibodies and high thyroidal radioactive iodine uptake.

    Fujii S, Miwa U, Seta T, Ohoka T, Mizukami Y.

    Intern Med. 2003 Aug;42(8):704-9.PMID: 12924496 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Hyperthyroidism.

    van Haeften TW.

    Lancet. 2003 Nov 8;362(9395):1584. No abstract available. PMID: 14615126 [PubMed - indexed for MEDLINE]Related articles

    7.

    [The immune and nonimmune genesis of goiter]

    Grigorie D.

    Endocrinologie. 1990 Jul-Dec;28(3-4):95-106. Review. French. No abstract available. PMID: 1983320 [PubMed - indexed for MEDLINE]Related articles

    8.

    The transition of subacute thyroiditis to Graves' disease as evidenced by diagnostic imaging.

    Bennedbaek FN, Gram J, Hegedüs L.

    Thyroid. 1996 Oct;6(5):457-9.PMID: 8936671 [PubMed - indexed for MEDLINE]Related articles

    9.

    Relapse of Graves' disease after subacute thyroiditis.

    Grunenberger F, Chenard MP, Weber JC, Jaeck D, Schlienger JL.

    Thyroid. 1998 Aug;8(8):683-5.PMID: 9737364 [PubMed - indexed for MEDLINE]Related articles

    10.

    Potential pathogenicity of autoantibodies to thyrotropin receptor in treated, euthyroid patients with Graves' disease.

    Banga JP, Harris PE.

    Eur J Endocrinol. 1998 Aug;139(2):139-42. Review. No abstract available. PMID: 9724064 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Appearance of anti TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma.

    Regalbuto C, Salamone S, Scollo C, Vigneri R, Pezzino V.

    J Endocrinol Invest. 1999 Feb;22(2):147-50.PMID: 10195384 [PubMed - indexed for MEDLINE]Related articles

    12.

    Development of Graves' hyperthyroidism after radioiodine treatment for a toxic nodule: is the hyperthyroidism always triggered by 1311 therapy?

    Niepomniszcze H, Pitoia F, Goodall C, Manavela M, Bruno OD.

    Thyroid. 2001 Oct;11(10):991. No abstract available. PMID: 11716050 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Effect of radioactive iodine treatment on TSH receptor antibodies in Basedow's disease]

    Heshmati HM, Dagousset F, Izembart M, Clerc J.

    Presse Med. 1992 Feb 15;21(6):268. French. No abstract available. PMID: 1532644 [PubMed - indexed for MEDLINE]Related articles

    14.

    Long-term effects of radioiodine on thyrotrophin receptor antibodies in Graves' disease.

    Aizawa Y, Yoshida K, Kaise N, Kaise K, Fukazawa H, Kiso Y, Mori K, Sayama N, Kikuchi K, Abe K.

    Clin Endocrinol (Oxf). 1995 May;42(5):517-22.PMID: 7621571 [PubMed - indexed for MEDLINE]Related articles

    15.

    Immunoprecipitation analysis of pathological autoantibodies in Graves' patients' sera using biotinylated human thyrotropin receptor labeled with 125I-neutravidiny.

    Minich WB, Weymayer JD, Loos U.

    Exp Clin Endocrinol Diabetes. 1999;107(8):555-60.PMID: 10612487 [PubMed - indexed for MEDLINE]Related articles

    16.

    An unusual case of Marine-Lenhart syndrome.

    El-Kaissi S, Kotowicz MA, Goodear M, Wall JR.

    Thyroid. 2003 Oct;13(10):993-4. No abstract available. PMID: 14611711 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Autoimmune reactions in diffuse toxic goiter after treatment with radioactive iodine]

    Mazepa MA, Parashchak AP, Tomashivskaia LV, Rypan VS, Ivano-Frankovsk.

    Med Radiol (Mosk). 1976 Feb;21(2):72-3. Russian. No abstract available. PMID: 946323 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Current methods of radionuclide diagnosis and radiodine therapy in toxic goiter]

    Purizhanskiĭ II, Lyzhina VD, Romanenko AM, Lisenkov PI.

    Med Radiol (Mosk). 1980 Dec;25(12):53-7. Russian. No abstract available. PMID: 6894013 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Gamma-camera functional scintigraphy in the differential diagnosis of Basedow's disease: results in 423 patients]

    Baum RP, Hör G.

    Rontgenpraxis. 1986 Dec;39(12):425-8. German. No abstract available. PMID: 3824080 [PubMed - indexed for MEDLINE]Related articles

    20.

    Ophthalmic Graves' disease. Diagnosis and pathogenesis.

    Hall R, Kirkham K, Doniach D, el-Kabir D.

    Lancet. 1970 Feb 21;1(7643):375-8. No abstract available. PMID: 4189686 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data